Marcelo Costamilan Rombaldi

McGill University, Jewish General Hospital

Papers

Total Citations

H-Index

About

Dr. Marcelo Costamilan Rombaldi is a pioneering gynecologic oncologist whose work centers on advancing robotic surgery for the management of ovarian cancer. His most influential research, published in 2019, demonstrates the feasibility and safety of incorporating robotic techniques after neoadjuvant chemotherapy, a finding that has garnered 43 citations and reshaped surgical approaches for complex ovarian malignancies. Dr. Rombaldi is equally recognized for his commitment to patient-centered outcomes, as evidenced by his 2016 study on minimizing pain medication use and associated costs following robotic surgery (22 citations). This work highlights his dedication to reducing opioid reliance and improving recovery while lowering healthcare expenditures. Beyond these contributions, his broader research portfolio explores the intersection of minimally invasive surgery, oncologic precision, and cost-effectiveness, making him a key voice in the evolution of gynecologic oncology. Dr. Rombaldi’s achievements underscore a career defined by innovation—bridging technical surgical advances with tangible benefits for patients and healthcare systems alike.